Abstract:Thioredoxin-interacting protein (TXNIP) plays a critical role in glucose metabolism and redox signaling. TXNIP has recently emerged as a potent tumor suppressor in various cancer models. In previous studies, we found TXNIP was activated by UNC0642, an inhibitor of histone methyltransferase, in MDA-MB-231 breast cancer cells. TXNIP activation was coupled with significant suppression of cell proliferation and tumor growth. In contrast, TXNIP knockdown increased MDA-MB-231 cell proliferation and in tumor growth and metastasis in vivo. TXNIP-reconstitution in TXNIP-deficient HCC1954 cells reduced cell proliferation and migration coupled with increased reactive oxygen species production. TXNIP-reconstitution also significantly decreased mitochondrial respiration, mitochondrial membrane potential and glycolysis in HCC1954 cells. To understand the mechanisms underlying TXNIP's antitumor activity, we performed co-immunoprecipitation and proteomic analyses to uncover TXNIP-interacting proteins. We identified calpastatin (CAST) as a novel TXNIP-interacting protein in breast cancer cells. CAST is an endogenous inhibitor of calpains, a family of calcium-activated cysteine proteases. Intriguingly, CAST association with TXNIP was readily detectable in TXNIP-low, but not in TXNIP-high breast cancer cells. The disassociation of CAST from TXNIP in TXNIP-high cells might allow CAST to inhibit calpain activity to augment TXNIP's antitumor function. Through RNAseq analysis, we identified a positive correlation between TXNIP expression and IL-24 activation in various breast cancer cells, which were also confirmed by western blotting. IL-24 has emerged as an important cancer therapy target because of its role in promoting cancer-specific apoptosis. Our data also demonstrated that TXNIP upregulated the level of IL-24 and downregulated STAT-3. Moreover, TXNIP exerts multifaceted effects on BC development through the IL24-STAT3 signaling axis, deepening our understanding of its complex role in the disease. Taken together, these studies identified novel TNXIP-dependent pathways and their potential new mechanisms in breast cancer pathogenesis with significant clinical implications. Citation Format: Jasvinder Singh, Bindeshwar Sah, Robert Clarke, Liang Liu. Identification of novel TXNIP-dependent antitumor pathways in breast cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 4378.

Structural Basis for a Novel Interaction Between TXNIP and Vav2.

Structural basis for the regulatory role of the PPxY motifs in the thioredoxin-interacting protein TXNIP.

Identification and structural basis for a novel interaction between Vav2 and Arap3.

Distinct Domains for Anti- and Pro-apoptotic Activities of IEX-1

The Ubiquitin Ligase Itch Regulates Apoptosis by Targeting Thioredoxin-interacting Protein for Ubiquitin-dependent Degradation

TXNIP: A Double-Edged Sword in Disease and Therapeutic Outlook

Intracellular shuttling and mitochondrial function of thioredoxin-interacting protein

Biochemical and NMR characterization of the interactions of Vav2-SH2 domain with lipids and the EphA2 juxtamembrane region on membrane.

Solution Structure of the First SH3 Domain of Human Vinexin and Its Interaction with Vinculin Peptides

Characterization and Immune Function of the Thioredoxin-Interacting Protein (TXNIP) from Litopenaeus Vannamei.

TXNIP: A key protein in the cellular stress response pathway and a potential therapeutic target

Structural Elucidation of the Binding of the Vav‐SH2 Domain to the EphA2 Cytoplasmic Region

High-resolution crystal structure of human Dim2/TXNL4B.

Vav2 is a novel APP-interacting protein that regulates APP protein level

Structural Basis for TNIP1 Binding to FIP200 During Mitophagy

The role and mechanism of thioredoxin-interacting protein in ischemia-reperfusion injury

Structural Investigation of the Interaction Between the Tandem SH3 Domains of C-Cbl-associated Protein and Vinculin.

Structural Basis of the Interaction between Human Axin2 and SIAH1 in the Wnt/β-Catenin Signaling Pathway

Structural basis for the immune recognition and selectivity of the immune receptor PVRIG for ligand Nectin-2

Abstract 4378: Identification of novel TXNIP-dependent antitumor pathways in breast cancer